Member Info for Jarv55

https://www.worldometers.info/coronavirus/#countries

https://news.sky.com/story/coronavirus-bruised-by-face-masks-nurses-show-the-impact-of-fighting-the-pandemic-11955457

https://news.sky.com/story/coronavirus-ireland-to-close-all-schools-and-colleges-until-end-of-march-11956087

Why so long to declare pandemic?

Though the disease spread beyond China in January, WHO have refrained from descriving the disease as pandemic until now.

That's because the virus spread beyond the origin country had not yet been sustained for a significant amount of time.

Now that the disease is spreading from person to person within countries outside of China, rather than affecting people who had recently visited the affected are it can be classed as pandemic.
What will happen now?

Following the WHO announcement the UK look set to step up their fight against Covid-19 and move from the 'contain' phase of their action plan to the 'delay' phase.

Once the new phase of delay is triggered, officials are likely to encourage elderly and vulnerable people to start “social distancing”. There may also be a recommendation for more people to work at home.

Measures such as school closures and banning public gatherings, two major steps of the delay phase set out in the Government’s coronavirus action plan last week, may not yet be given the go ahead.

B2h No they don't need the equipment there are two different types of test.

Read the last paragraph more revenues incoming.
Graham Mullis, Chief Executive Officer of Novacyt, commented:

"We believe the commercial demand for and interest in our COVID-19 test could continue for several months as the virus continues to spread from country to country. We are therefore ensuring we are fully prepared to meet the increasing demand for the product, as we continue to position Novacyt to support the global response to monitor and contain the COVID-19 outbreak. The sale of our COVID-19 test has already generated significant revenue for the Company, which we expect to continue given the increasing demand for the test.



"In addition, we believe interest in our COVID-19 test will have a positive, long-term impact on Novacyt as new customers look to purchase our broader product range. We are already seeing an increased demand for our B2B capabilities as customers look to utilise our molecular design and development capabilities.

During the past two weeks, Primerdesign has scaled up its manufacturing capacity for the COVID-19 test and is currently meeting demand. The Company has purchased enough raw materials to manufacture 3.5 million COVID-19 tests. In addition, the Company has significantly increased its manufacturing capacity by appointing a third-party manufacturer, which specialises in high quality, GMP pharma and molecular diagnostic outsourcing and is based in mainland Europe. It is expected that the combination of the two manufacturing operations will support production of up to 2 million COVID-19 tests per month, which increases capacity by a factor of 10. This increase in output will be available within the next two weeks. The purchase of further raw materials and a further scale up of manufacturing capacity is possible under this outsourcing agreement.

Who ever they have partnered with has the ability to upscale even further than 2 million tests per month.

This is a gem of an rns it just keeps giving if you actually read it properly
"In addition, we believe interest in our COVID-19 test will have a positive, long-term impact on Novacyt as new customers look to purchase our broader product range. We are already seeing an increased demand for our B2B capabilities as customers look to utilise our molecular design and development capabilities.

https://www.independent.co.uk/news/health/coronavirus-news-live-uk-cases-trump-us-travel-ban-europe-pandemic-delay-phase-a9396186.html

Shardster I am hearing they are thinking of shutting all schools

50 plus other countries

Novacyt is pleased to report the completion of a formal evaluation of its COVID-19 test by Public Health England (PHE) and is very satisfied with the performance assessment of its test. The Company believes this data represents an important endorsement of the claims made to date in relation to the quality and performance of its COVID-19 test. It is understood this report will be shared with the NHS to support their decisions for general COVID-19 testing across the UK. The Company therefore expects to see an increase in the number of NHS hospitals purchasing Primerdesign's COVID-19 test

Read the rns again and again
The Company is working closely with the US Food and Drug Administration (FDA) to meet the stringent requirements for Emergency Use Approval (EUA) of its COVID-19 test and is hopeful its application will be successful. A number of other national health agencies continue to review Novacyt's test, but the Company is unable to indicate when these approvals might be granted. As soon as an approval is granted, the Company will communicate this.

A number of other national health agencies continue to review Novacyt's test

https://www.independent.co.uk/news/health/coronavirus-news-live-uk-cases-trump-us-travel-ban-europe-pandemic-delay-phase-a9396186.html

Tinatots that actually isn't true I have seen many companies go to a 200mc on nothing no revenues and markets are forward thinking. The market is waitng for fda and Cfda approval and the Nhs to announce they are using our test when that happens all bets are off.

it is clear that the demand for, and interest in, the Company's tests remains very high and the Directors' key focus is on ensuring Primerdesign can service the demand from as many customers as possible.

I expect a JV here

During the past two weeks, Primerdesign has scaled up its manufacturing capacity for the COVID-19 test and is currently meeting demand. The Company has purchased enough raw materials to manufacture 3.5 million COVID-19 tests. In addition, the Company has significantly increased its manufacturing capacity by appointing a third-party manufacturer, which specialises in high quality, GMP pharma and molecular diagnostic outsourcing and is based in mainland Europe. It is expected that the combination of the two manufacturing operations will support production of up to 2 million COVID-19 tests per month, which increases capacity by a factor of 10. This increase in output will be available within the next two weeks. The purchase of further raw materials and a further scale up of manufacturing capacity is possible under this outsourcing agreement.

Lets say £2 mill x 10 pe of 16

As of 11 March 2020, Primerdesign has sold and received orders for over £2.3 million (€2.6 million) of its CE-Mark and research use only (RUO) COVID-19 tests, which represents approximately five months of sales for the division under normal circumstances. This is additional revenue to the core Novacyt business, which has also started the year strongly. In the past two weeks, the number of countries the Company is selling its COVID-19 test into has doubled to over 50, which is expected to increase further as the virus continues to spread. Currently, the Company is seeing significant sales from Europe and from a number of new and existing distribution partners across the Middle East.

Then we have this as well

Primerdesign has also signed its first major distribution agreement for the COVID-19 test with a global life sciences company to supply the test to two Asian territories outside mainland China. Initial sales, which are subject to local emergency use approval, are anticipated to be £2.1m (€2.5m) during the first six months of the agreement. It is expected that the first sales under this agreement will take place in March 2020.

Srong afternoon incoming as the rainbow chasers leave and sticky holders come in. Grahame get us a full Nasdaq listing show these bedwetters how the Americans value a company.

great rns well done Ncyt

https://twitter.com/Jarvy55/status/1238004631747334147?s=20

http://www.primerdesign.co.uk/about/distributors